Robert Leibenluft
FTC Takes Aim at the Issue of Competition for Biologics and Follow-on Biologics
Focus on Regulation ·
FTC finalizes rule extending reporting requirements for pharmaceutical patent transfers
Focus on Regulation ·
Federal judge allows discovery to proceed in REMS duty to deal dispute
Focus on Regulation ·
FTC Commissioner Offers Post-Actavis Analysis & Predictions
Focus on Regulation ·